Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends?
Fortress Biotech is considering whether to pay deferred preferred stock dividends. The company currently has a strong financial position with $256 million in cash and only $39 million in debt. This situation raises questions about the timing and necessity of dividend payments.
- ▪Fortress Biotech holds $256 million in cash and has $39 million in debt.
- ▪The company's balance sheet is described as a 'fortress'.
- ▪The decision on paying deferred preferred stock dividends is under consideration.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Dividends Analysis","item":"https://seekingalpha.com/dividends"},{"@type":"ListItem","position":3,"name":"Dividend Ideas","item":"https://seekingalpha.com/dividends/dividend-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4910163-fortress-biotech-is-it-time-to-pay-deferred-preferred-stock-dividends"},"author":{"@type":"Person","name":"Richard…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.